88 related articles for article (PubMed ID: 6097491)
1. Repeated micro-monocyte adherence inhibition assay: a new technique of leukocyte adherence inhibition to detect tumor immunity in patients with hepatoma.
Kumagai N; Morizane T; Inagaki Y; Nakamura T; Tsuchimoto K; Watanabe T; Tsuchiya M
Gan; 1984 Nov; 75(11):1017-24. PubMed ID: 6097491
[TBL] [Abstract][Full Text] [Related]
2. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
3. A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes.
Morizane T; Sjögren HO
Int J Cancer; 1983 Jun; 31(6):803-12. PubMed ID: 6345408
[TBL] [Abstract][Full Text] [Related]
4. Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively.
Morizane T; Sjögren HO
Int J Cancer; 1983 Jun; 31(6):813-6. PubMed ID: 6345409
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
Lee C; Chen S; Lin T
Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of leukocyte adherence inhibition (LAI) test in primary and secondary hepatic malignancies.
Tantry BV; Jain AK; Gupta S; Gupta JP
J Surg Oncol; 1984 Nov; 27(3):159-62. PubMed ID: 6092784
[TBL] [Abstract][Full Text] [Related]
7. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
8. Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction.
Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Holyoke ED
Cancer Res; 1979 Feb; 39(2 Pt 2):587-92. PubMed ID: 367585
[TBL] [Abstract][Full Text] [Related]
9. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
10. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
Thomson DM; Halliday WJ; Phelan K
J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
[TBL] [Abstract][Full Text] [Related]
12. Leucocyte adherence inhibition assay for immunodiagnosis of hepatocellular carcinoma.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):336-43. PubMed ID: 6092190
[TBL] [Abstract][Full Text] [Related]
13. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
14. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test.
Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M
Cancer Res; 1985 Sep; 45(9):4473-7. PubMed ID: 2992780
[TBL] [Abstract][Full Text] [Related]
15. Application of the indirect tube LAI assay in the study of cell-mediated immunity in rats immunized with B77 tumor cells.
Kalafut F; Hung PM; Novotná L; Klobusická M
Neoplasma; 1980; 27(5):525-31. PubMed ID: 7015159
[TBL] [Abstract][Full Text] [Related]
16. New micro-glass-tube leukocyte adherence inhibition assay assessing cell adherence of mononuclear cell subpopulations defined by monoclonal antibodies.
Morizane T; Satoh I; Kumagai N; Saito H; Iino A; Inagaki Y; Watanabe T; Tsuchimoto K; Tsuchiya M
J Immunol Methods; 1986 Jul; 91(2):225-9. PubMed ID: 3090150
[TBL] [Abstract][Full Text] [Related]
17. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
Raina S; Russo AJ; Jenkins D; Goldrosen MH
Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
[TBL] [Abstract][Full Text] [Related]
18. Superoxide (O2-) assay monocyte adherence test for the detection of cell-mediated immunity in cancer patients.
Yagawa K; Kaku M; Ichinose Y; Hayashi S; Nakanishi M; Nomura Y; Shigematsu N
Oncology; 1987; 44(3):142-4. PubMed ID: 3037461
[TBL] [Abstract][Full Text] [Related]
19. Cell-populations involved in the humoral leukocyte adherence inhibition reaction. The T8-suppressor/cytotoxic cells are both effectors and responders.
Moskaug JO; Kotlar HK; Sanner T
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):149-56. PubMed ID: 2965016
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
